These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 30053126)

  • 1. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
    Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
    Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
    Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
    BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
    Sintupisut N; Liu PL; Yeang CH
    Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.
    Cho HJ; Zhao J; Jung SW; Ladewig E; Kong DS; Suh YL; Lee Y; Kim D; Ahn SH; Bordyuh M; Kang HJ; Sa JK; Seo YJ; Kim ST; Lim DH; Dho YS; Lee JI; Seol HJ; Choi JW; Park WY; Park CK; Rabadan R; Nam DH
    Neuro Oncol; 2019 Jan; 21(1):47-58. PubMed ID: 30085274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.
    Sa JK; Kim SH; Lee JK; Cho HJ; Shin YJ; Shin H; Koo H; Kim D; Lee M; Kang W; Hong SH; Kim JY; Park YW; Song SW; Lee SJ; Joo KM; Nam DH
    Neuro Oncol; 2019 Feb; 21(2):222-233. PubMed ID: 29939324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
    Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
    J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated genomic analysis of survival outliers in glioblastoma.
    Peng S; Dhruv H; Armstrong B; Salhia B; Legendre C; Kiefer J; Parks J; Virk S; Sloan AE; Ostrom QT; Barnholtz-Sloan JS; Tran NL; Berens ME
    Neuro Oncol; 2017 Jun; 19(6):833-844. PubMed ID: 27932423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA sequencing and Immunohistochemistry Reveal
    Esteve-Codina A; Alameda F; Carrato C; Pineda E; Arpí O; Martinez-García M; Mallo M; Gut M; Dabad M; Tortosa A; Del Barco S; Capellades J; Puig J; Gallego O; Pujol T; Oleaga L; Gil-Gil M; de Quintana-Schmidt C; Valduvieco I; Martinez-Cardús A; Bellosillo B; Muñoz-Marmol AM; Esteve A; Domenech M; Camins A; Craven-Bartle J; Villa S; Marruecos J; Domenech S; de la Iglesia N; Balana C
    Clin Cancer Res; 2021 Jan; 27(2):645-655. PubMed ID: 33106291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
    Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
    Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.
    Zhang JX; Zhang J; Yan W; Wang YY; Han L; Yue X; Liu N; You YP; Jiang T; Pu PY; Kang CS
    Neuro Oncol; 2013 Mar; 15(3):279-89. PubMed ID: 23295773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.
    Murnyák B; Kouhsari MC; Hershkovitch R; Kálmán B; Marko-Varga G; Klekner Á; Hortobágyi T
    Oncotarget; 2017 Jul; 8(28):46348-46362. PubMed ID: 28654422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic analyses reveal the key pathways and genes in the CXCR4 mediated mesenchymal subtype of glioblastoma.
    Yi L; Tong L; Li T; Hai L; Abeysekera IR; Tao Z; Ma H; Liu P; Xie Y; Li J; Yuan F; Yu S; Yang X
    Mol Med Rep; 2018 Jul; 18(1):741-748. PubMed ID: 29767255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
    Patil V; Mahalingam K
    Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus.
    Shukla S; Pia Patric IR; Thinagararjan S; Srinivasan S; Mondal B; Hegde AS; Chandramouli BA; Santosh V; Arivazhagan A; Somasundaram K
    Cancer Res; 2013 Nov; 73(22):6563-73. PubMed ID: 24078801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival kinase genes present prognostic significance in glioblastoma.
    Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
    Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
    Li M; Long S; Hu J; Wang Z; Geng C; Ou S
    Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma.
    Park J; Shim JK; Yoon SJ; Kim SH; Chang JH; Kang SG
    Sci Rep; 2019 Jul; 9(1):10555. PubMed ID: 31332251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses.
    Yuan F; Yi L; Hai L; Wang Y; Yang Y; Li T; Tong L; Ma H; Liu P; Ming H; Ren B; Yu S; Lin Y; Yang X
    Dis Markers; 2019; 2019():7049294. PubMed ID: 31772693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.